prior to joining novartis he was head of h j heinz company s north american business from 2002 to 2006 he was also a non executive director of astrazeneca from 2002 to 2007 as well as an advisor for the blackstone group jimenez joined novartis in 2007 as division head of novartis pharmaceutical and was named ceo in 2010 by his predecessor and chairman daniel vasella during his time at novartis jimenez increasingly applied standard business metrics to pharma cash flow purchasing and competitive bidding confident that his experience in consumer goods would help to realize improvements in novartis operations his cost cutting moves focused mostly on marketing and administration came steadily with more than a billion cut in 2010 and even more than that in 2011 jimenez joined the board of directors at general motors on june 9 2015 jimenez resigned from novartis leaving in february 2018 and was succeeded by vasant narasimhan he joined the board of directors of san francisco biotech startup ubiome in september 2018 and stepped down in april 2019 to run his own venture fund